Hosted by the Institute of Clinical and Translational Sciences (ICTS) and the WashU School of Medicine
To RSVP, please contact Carol Sharp.
Agenda – Program Outline
12:00p Introduction and lunch
12:30p Keynote presentation John DiPersio (WashU Medicine) – “Building a Career in Oncology”
1:15p Felicia Gomez (WashU Medicine) – “Ultra-deep Sequencing of Classical Hodgkin lymphoma (cHL) Reveals Novel Somatic Mutations and Exemplifies the Utility of Deep Sequencing in the Characterization of Rare Malignant Cells”
1:35p Tanner Johanns (WashU Medicine) – “Identification of Novel Immunogenic Targets for the Treatment of Glioblastoma”
1:55p Michael Alberti (WashU Pathology & Immunology) – “Mutant U2AF1S34F and U2AF1Q157P/R Induce Distinct RNA Splicing and Hematopoietic Phenotypes in Vivo”
2:30p Francesca Ferraro (WashU Medicine) – “The Molecular Basis of Favorable Risk AML”
2:50p Jeffrey Ward (WashU Medicine) – “Remodeling of Intratumoral Lymphoid and Myeloid Compartments by Effective Cancer Immunotherapies”
3:10p Todd Fehniger (WashU Medicine) – “Getting Funded: Do’s and Don’ts”
Reception immediately following in the EPNEC Lobby Area.